Cargando…
Variation in Antiosteoporotic Drug Prescribing and Spending Across Spain. A Population-Based Ecological Cross-Sectional Study
Introduction: Evidence has shown that utilization of antiosteoporotic medications does not correspond with risk, and studies on other therapies have shown that adequacy of pharmaceutical prescribing might vary between regions. Nevertheless, very few studies have addressed the variability in osteopor...
Autores principales: | Sanfélix-Gimeno, Gabriel, Librero-López, Julián, Modroño-Riaño, Gracia, Peiró, Salvador, Rodríguez-Bernal, Clara L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909183/ https://www.ncbi.nlm.nih.gov/pubmed/29706889 http://dx.doi.org/10.3389/fphar.2018.00342 |
Ejemplares similares
-
Overuse and Underuse of Antiosteoporotic Treatments According to Highly Influential Osteoporosis Guidelines: A Population-Based Cross-Sectional Study in Spain
por: Sanfélix-Gimeno, Gabriel, et al.
Publicado: (2015) -
A Multilevel Analysis of Real-World Variations in Oral Anticoagulation Initiation for Atrial Fibrillation in Valencia, a European Region
por: García-Sempere, Aníbal, et al.
Publicado: (2017) -
Variations in osteoporosis medication utilization. A population-based ecological cross-sectional study in the region of Valencia, Spain
por: Sanfélix-Gimeno, Gabriel, et al.
Publicado: (2018) -
Impact of Drug Safety Warnings and Cost-Sharing Policies on Osteoporosis Drug Utilization in Spain: A Major Reduction But With the Persistence of Over and Underuse. Data From the ESOSVAL Cohort From 2009 to 2015
por: Hurtado-Navarro, Isabel, et al.
Publicado: (2019) -
Are prescribing doctors sensitive to the price that their patients have to pay in the Spanish National Health System?
por: González López-Valcárcel, Beatriz, et al.
Publicado: (2011)